Skip to main content

Published locations for Alemtuzumab May Be Superior to Interferon Beta-1a in Patients With MS—Results From the CARE-MS II Study

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Alemtuzumab May Be Superior to Interferon Beta-1a in Patients With MS—Results From the CARE-MS II Study

User login

  • Reset your password
  • /content/alemtuzumab-may-be-superior-interferon-beta-1a-patients-ms-results-care-ms-ii-study
  • /neurologyreviews/article/73504/multiple-sclerosis/alemtuzumab-may-be-superior-interferon-beta-1a
  • /multiplesclerosishub/article/73504/multiple-sclerosis/alemtuzumab-may-be-superior-interferon-beta-1a
  • /neurology/article/73504/multiple-sclerosis/alemtuzumab-may-be-superior-interferon-beta-1a-patients
  • /neurology/msresourcecenter/article/73504/multiple-sclerosis/alemtuzumab-may-be-superior-interferon